Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design-Reference-Cited by-同舟云学术

Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design

Published:2018-01-09 Issue:6 Volume:44 Page:923-933
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Vanza Jigar¹,Jani Parva¹,Pandya Nilima¹,Tandel Hemal¹

Affiliation:

1. Faculty of Pharmacy, The Maharaja Sayajirao University of Baroda, Vadodara, India

Funder

Lipoid GmbH

TIFAC-CORE

M.S. University of Baroda

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2017.1421661

Reference49 articles.

1. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?

2. New strategies to deliver anticancer drugs to brain tumors

3. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery

4. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy

5. Temozolomide in malignant gliomas: current use and future targets

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocarriers for the treatment of glioblastoma multiforme: A succinct review of conventional and repositioned drugs in the last decade;Archiv der Pharmazie;2024-07-29

2. Terpenes-Modified Lipid Nanosystems for Temozolomide, Improving Cytotoxicity against Glioblastoma Human Cancer Cells In Vitro;Nanomaterials;2023-12-24

3. Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment;International Journal of Molecular Sciences;2023-10-06

4. DOE supported optimization of biodegradable polymeric nanoparticles based dry powder inhaler for targeted delivery of afatinib in non-small cell lung cancer;Journal of Drug Delivery Science and Technology;2023-06

5. LIPOSOMAL DRY POWDER INHALER: NOVEL PULMONARY TARGETED DRUG DELIVERY SYSTEM FOR THE TREATMENT OF LUNG CANCER;International Journal of Applied Pharmaceutics;2023-01-07